Syros Pharmaceuticals (SYRS) Earnings
|
Expand Research on SYRS
| Next EPS Date | 11/18/26 *Est. | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +40.7% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +0.2% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/21/26  |
Q226 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/18/26 |
Q226 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/17/26 |
Q226 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/13/26 |
Q226 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 7/29/26 |
Q226 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/19/26 |
Q226 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/25/26 |
Q126 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/19/26 |
Q126 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
